Drug Trial Radar · NCT07811882
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)
Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
95
Actual
Start
Oct 10, 2025
Primary completion
Jun 17, 2026
Study completion Jul 1, 2026
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Sep 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is Cohort B1 of the Platform study (NCT05750628) to evaluate the efficacy and safety of INE963 + Cipargamin in participants with uncomplicated Plasmodium falciparum malaria.
Conditions
- Uncomplicated Plasmodium Falciparum Malaria
Interventions
KAE609 (Cipargamin)Drug
oral KAE609 (Cipargamin)
SoC (Coartem)Drug
SoC (Coartem)
INE963Drug
oral INE963
Primary outcomes
What the sponsor says the trial is designed to measure.
- Polymerase chain reaction (PCR) corrected adequate clinical and parasitological response (ACPR)Time frame: Day 29
Locations
13 sites in 7 countries. Site status is shown where the registry gives one.
Novartis Investigative Site
Banfora, Burkina Faso
Novartis Investigative Site
Nanoro, Burkina Faso
Novartis Investigative Site
Abidjan, Côte d’Ivoire
Novartis Investigative Site
Azaguié, Côte d’Ivoire
Novartis Investigative Site
Lambaréné, Gabon
Novartis Investigative Site
Libreville, Gabon
Novartis Investigative Site
Kintampo, Ghana
Novartis Investigative Site
Navrongo, Ghana
Novartis Investigative Site
Ahero, Kenya
Novartis Investigative Site
Kisumu, Kenya
Novartis Investigative Site
Kigali, Rwanda
Novartis Investigative Site
Kampala, Uganda
Novartis Investigative Site
Tororo, Uganda
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.